Cargando…
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1
ABL gene translocations create constitutively active tyrosine kinases that are causative in chronic myeloid leukemia, acute lymphocytic leukemia and other hematopoietic malignancies. Consistent retention of ABL SH3/SH2 autoinhibitory domains, however, suggests that these leukemogenic tyrosine kinase...
Autores principales: | Thai, M, Ting, P Y, McLaughlin, J, Cheng, D, Müschen, M, Witte, O N, Colicelli, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049868/ https://www.ncbi.nlm.nih.gov/pubmed/21102429 http://dx.doi.org/10.1038/leu.2010.268 |
Ejemplares similares
-
RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinases
por: Balaji, Kavitha, et al.
Publicado: (2013) -
Identification of Small Molecules that Disrupt Signaling between ABL and Its Positive Regulator RIN1
por: Ting, Pamela Y., et al.
Publicado: (2015) -
RIN3 Is a Negative Regulator of Mast Cell Responses to SCF
por: Janson, Christine, et al.
Publicado: (2012) -
El Rin : historia, mitos y realidades /
por: Febvre, Lucien, 1878-1956
Publicado: (2004) -
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
por: Greulich, Heidi, et al.
Publicado: (2005)